Cargando…
Identification of key genes and pathways revealing the central regulatory mechanism of brain-derived glucagon-like peptide-1 on obesity using bioinformatics analysis
OBJECTIVE: Central glucagon-like peptide-1 (GLP-1) is a target in treating obesity due to its effect on suppressing appetite, but the possible downstream key genes that GLP-1 regulated have not been studied in depth. This study intends to screen out the downstream feeding regulation genes of central...
Autores principales: | Shao, Yuwei, Tian, Jun, Yang, Yanan, Hu, Yan, Zhu, Ye, Shu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389235/ https://www.ncbi.nlm.nih.gov/pubmed/35992905 http://dx.doi.org/10.3389/fnins.2022.931161 |
Ejemplares similares
-
Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
por: Pocai, Alessandro, et al.
Publicado: (2009) -
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity
por: Anandhakrishnan, Ananthi, et al.
Publicado: (2016) -
Glucagon-like Peptide-1 Receptor Analogues for the Treatment of Obesity
por: Williams, David M, et al.
Publicado: (2022) -
Antagonistic interaction between central glucagon-like Peptide-1 and oxytocin on diet-induced obesity mice
por: Lee, Jeonghoon, et al.
Publicado: (2020) -
Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor
por: Rode, Anna K. O., et al.
Publicado: (2022)